[1]
S. Srivastava, S. Agarwal, Y. Gulati, A. K. Singh, and P. Aggarwal, “Determining the role of SGLT2 inhibitors (dapagliflozin) on progression of proteinuria among non-diabetic adult patients with chronic kidney disease: a randomized controlled trial”, Int J Adv Med, vol. 12, no. 6, pp. 553–557, Oct. 2025.